Ankita P. Desai, MD, is a physician in the Division of Pediatric Infectious Diseases and Rheumatology and Director of Antimicrobial Stewardship at University Hospitals Rainbow Babies & Children’s Hospital. She is Assistant Professor, Pediatrics at Case Western Reserve University School of Medicine.
Dr. Desai is board certified in pediatrics and pediatric infectious diseases. Her special interest is the responsible use of antibiotics and microbiology.
She earned her undergraduate degree cum laude from The University of Akron, Akron, Ohio, and received her medical degree from Northeast Ohio Medical University, Rootstown, Ohio. Dr. Desai completed her residency in pediatrics at Children’s National Medical Center, Washington, DC, and a fellowship in pediatric infectious diseases at Emory University School of Medicine, Atlanta, Ga.
Dr. Desai joined the UH Rainbow Babies & Children's Hospital staff in 2013. Her research interests include pediatric pneumonia and causes of fever in children with cancer.
Dr. Desai has published articles in peer-reviewed journals and presented at medical meetings. She is a member of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics and American Society for Microbiology.
Causes of fever in children with cancer
- Antimicrobial Stewardship
- Pediatric Infectious Diseases - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Children's Healthcare Of Atlanta - Egleston Hospital (2010 - 2013)
Residency | Pediatrics
Pediatrics - Children's National Medical Center (2006 - 2009)
Northeast Ohio Medical University (NEOMED) (2006)
University Of Akron (2002)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Ankita Desai did not disclose any Outside Relationships with Industry.